Tái thông toàn bộ hay từng phần mạch vành ở người đau thắt ngực ổn định mạn tính

32 267 0
Tái thông toàn bộ hay từng phần mạch vành ở người đau thắt ngực ổn định mạn tính

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

Complete or partial revascularization in patients with chronic stable angina: why and how? Peter M Pollak MD ©2011 MFMER | 3138928-1 Disclosure Relevant Financial Relationship(s) • None Off Label Usage • None ©2012 MFMER | 3208595-2 Revascularization, Ischemia, & Completeness… • Challenges in defining complete revascularization • Presence & degree of ischemia is associated with adverse outcomes • Relief of ischemia associated with improved outcomes • More complete revascularization is associated with improved outcomes • Surgical revascularization appears more durable than percutaneous revascularization ©2011 MFMER | 3138928-3 Challenges in assessing complete revascularization • There has been no universal definition • Anatomic criteria using stenosis >50% have been common • Fails to describe physiology • Fails to account for viability • Jeopardy score & Functional SYNTAX may be better • Factors associated with IR are known predictors of adverse outcome • CTO, Calcific disease, poor EF, DM, CKD, prior MI ©2011 MFMER | 3138928-4 Angiographic stenosis ≠ functional stenosis 60% 20% Gössl M et al Circ Cardiovasc Interv 2012;5:597-604 WHY REVASCULARIZE? ©2011 MFMER | 3138928-6 Ischemic Burden Treated Medically Cardiac death (%) Cardiac Death at 1.9 Years 0% – 5% (n = 7,119) (n = 1,331) – 10% (n = 716) 11 – 20% (n = 545) > 20% (n = 252) Total myocardial ischemia (%) myocardial ischemia  cardiac death Hachamovitch R, et al Circulation 2003;107:2900-2907 Ischemia Reduction in COURAGE Survival Stratified by Residual Ischemia Event-free survival 100 80 0% < 5% – 10% > 10% 60 40 20 More Residual ischemia  more events Shaw LJ, et al Circulation 2008;117:1283-1291 Revascularization vs Medical Therapy in Stable CAD: A Network Meta-Analysis 100 RCTs – 93,553 patients randomized Follow-up of 262,090 patient-years Pts randomized Follow-up 6,846 30,628 PY Med Rx Pts randomized CABG Follow-up 8,920 38,709 PY PTCA Pts randomized Follow-up Pts randomized Follow-up 14,802 25,096 PY EES 6,920 17,678 PY BMS Pts randomized Follow-up Pts randomized Follow-up 2,035 3,134 PY Pts randomized Follow-up R-ZES 9,187 27,384 PY 15,787 45,467 PY PES Pts randomized Follow-up 12,457 28,828 PY E-ZES SES Pts randomized Follow-up 19,391 45,679 PY The European Myocardial Revascularization Collaboration: BMJ, 2014 Revascularization vs Medical Therapy in Stable CAD: A Network Meta-Analysis Primary Endpoint: All-Cause Mortality 100 RCTs – 93,553 patients randomized 262,090 patient-years of follow-up 5,346 events for analysis Surgery CABG Early PCI techniques PTCA BMS Early-generation DES PES SES E-ZES New-generation DES R-ZES EES Rate ratio (95% CI) 0.80 (0.70, 0.91) 0.85 (0.68, 1.04) 0.92 (0.79, 1.05) 0.92 (0.75, 1.12) 0.91 (0.75, 1.10) 0.88 (0.69, 1.10) 0.65 (0.42, 1.00) 0.75 (0.59, 0.96) 0.3 Favors revascularization Favors medical therapy The European Myocardial Revascularization Collaboration: BMJ, 2014 Subsequent CABG Study, year Events/subgroup CR n/N IR n/N Risk ratio (95% CI) Mariani, 2001 1/44 2/147 1.67 (0.15-17.9) Kloeter, 2001 1/101 6/149 0.24 (0.03-2.01) van den Brand, 2002 8/406 17/170 0.19 (0.08-0.44) Ijsselmuiden, 2004 10/104 12/109 0.87 (0.39-1.93) Hannan, 2006 443/6817 1115/15,128 0.88 (0.79-0.98) Srinivas, 2007 15/135 77/1466 0.90 (0.52-1.55) Tamburino, 2008 3/212 9/296 0.46 (0.12-1.69) 56/3499 164/7795 0.76 (0.56-1.02) Hannan, 2009 Pooled 0.70 (0.52-0.95) 0.01 0.1 CR 10 100 IR P (heterogeneity)=0.03 I2=55.4 Aggarwal et al: EuroIntervention 7:1095, 2012 Repeat PCI Study, year Events/subgroup CR n/N IR n/N Risk ratio (95% CI) Mariani, 2001 5/44 14/147 1.19 (0.45-3.12) Kloeter, 2001 33/101 29/149 1.67 (1.09-2.58) van den Brand, 2002 53/406 17/170 1.30 (0.77-2.18) – – 0.94 (0.64-1.38) 22/104 34/109 0.67 (0.42-1.07) Srinivas, 2007 Ijsselmuiden, 2004 Hannan, 2006 Tamburino, 2008 Hannan, 2009 1602/6817 3372/13,807 0.96 (0.91-1.01) 34/212 93/296 0.51 (0.35-0.72) 472/3499 1617/7795 0.65 (0.59-0.71) Pooled 0.87 (0.69-1.11) 0.01 0.1 CR 10 100 IR P (heterogeneity)

Ngày đăng: 15/11/2016, 11:23

Từ khóa liên quan

Tài liệu cùng người dùng

  • Đang cập nhật ...

Tài liệu liên quan